Latest Blogs

Feb 01, 2023
Welcome to the first issue of ASCO Connection in 2023—we are kicking off the new year with a wide-ranging issue.
Jan 31, 2023
Even as I wrote the first paragraph of this article, I had 6 notifications on my iPhone. We all suffer from distraction nowadays! 
Jan 19, 2023
Dr. Kathryn DeCarli and Dr. Jonathan Marron consider the actions an oncologist must, ought, and should take when offering professional medical interpretation services to a patient.
Dec 08, 2022
ASCO’s delegation to the American Medical Association’s House of Delegates (AMA HOD) recently traveled to Honolulu for the Interim meeting. Our resolutions primarily focused on the threat of legislation that could criminalize medically necessary care in the wake of the Supreme Court’s decision...
Subscribe to this column

Don S. Dizon, MD, FACP, FASCO

Don S. Dizon, MD, FACP, FASCO, is a professor of medicine and professor of surgery at Brown University, director of the Pelvic Malignancies Program and Hematology-Oncology Outpatient Clinics at Lifespan Cancer Institute, and director of Medical Oncology and the Sexual Health First Responders Clinic at Rhode Island Hospital. He also serves as the head of community outreach and engagement of the Legorreta Cancer Center at Brown University. Dr. Dizon has served as past chair of ASCO's Social Media Working Group and the Cancer Communications Committee. In addition to his regular column on ASCOconnection.org, which has been honored with APEX awards in 2013 and 2014, he is a blogger for The Oncologist and a section editor of Gynecologic Oncology at UpToDate. Dr. Dizon is a member of the JCO Oncology Practice Editorial Board, and editor in chief of the ASCO Educational Book. Follow Dr. Dizon across social media channels @drdonsdizon. 

Disclosure.

Sep 12, 2017
I applaud the Foundation for Women’s Cancers for highlighting the importance of trials, and join them in their push for more trial options for not only my own patients, but for all patients with cancer.
Aug 29, 2017
As I prepare to take on a new professional position, I have been reflecting on what academic medicine means, and how to thrive in it.
Aug 01, 2017
Yes, "at least" my patient was still alive. But, at the end of the day, I knew that would not be comforting. “At least” is never enough, because when it comes to life, most of us—cancer or no cancer—always want more.
Jun 20, 2017
New immunotherapies are offering astounding responses, but my patient's remission came at the cost of debilitating toxicity. How much is too much to bear?
Jun 08, 2017
At the Plenary Session of this year’s ASCO Annual Meeting, the results of a longitudinal trial begun in 2007 showed me that patient engagement is much more important that I had imagined.
May 30, 2017
The phrase "the fight against cancer" assumes only two outcomes: remission or death, no middle ground. Today more than ever, nothing is further from reality.

Pages